아스트라제네카 ADR (AZN)

이름만 들어도 징그럽다 장난치니!

AstraZeneca's Dr Meme Pangslos tells the BBC in an interview to be aired tomorrow that 'There's no doubt we should have run the study a little bit differently' when referring to the covid vaccine trials. That's a bit of an understatement...They showed 62% efficacy on volunteers that included 'some' people over 55, and 90% on trail that included NO people people over 55.What does that say? It says that adding older people to the test group reduced efficacy by a third. AZ will not say what proportion of people in the inclusive trial were over 55. But here's a guess: was it a third??But then, astonishingly, AZ claimed that the reason for the higher 90% efficacy was not because there were no over 55s in the trial, but because the first jab, (administered in error), consisted of only half the intended amount of vaccine.Doesn't seem likely does it?What seems more likely is that this vaccine is ineffective for the very age group that needs it most. No wonder regulators are strug

미국 아렉시온 회사 인수했어여 프리미엄 40%주고 알랙시온은 현제 주가 37% 치솟음 ㅠ,ㅠ